Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.
Latest website image capture
Clouds background image

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for the odetiglucan and CDX-1140 study is displayed, including its terminated status, study details, eligibility criteria, outcomes, and locations.
    Difference
    50%
    Check dated 2026-11-08T12:30:03.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T13:18:23.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide notice about NIH terminology changes appears above the ClinicalTrials.gov study page, which is currently showing a 403 error.
    Difference
    1%
    Check dated 2026-10-25T13:11:06.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2, while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:11:27.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now shows revision v3.7.1 instead of v3.7.0. The study record itself still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T13:47:32.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    - The study page now shows a 403 Forbidden error, replacing the full trial details with an access-denied message. This makes the core information about the study unavailable to users.
    Difference
    19%
    Check dated 2026-09-20T08:50:41.000Z thumbnail image

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.